The Journal of Urology
Volume 182, Issue 5 , Pages 2242-2249 , November 2009

Men Older Than 70 Years Have Higher Risk Prostate Cancer and Poorer Survival in the Early and Late Prostate Specific Antigen Eras

  • Leon Sun

      Affiliations

    • Nothing to disclose.
  • ,
  • Arthur A. Caire

      Affiliations

    • Nothing to disclose.
  • ,
  • Cary N. Robertson

      Affiliations

    • Financial interest and/or other relationship with EDAP-Technomed and Cytogen.
  • ,
  • Daniel J. George

      Affiliations

    • Financial interest and/or other relationship with Novartis Pharmaceuticals, Pfizer Inc., Astra Zeneca, Roche, Cougar, Wyeth, Genentech, Bayer, Sanofi-Aventis and Molecular Insight.
  • ,
  • Thomas J. Polascik

      Affiliations

    • Financial interest and/or other relationship with Galil.
  • ,
  • Kelly E. Maloney

      Affiliations

    • Nothing to disclose.
  • ,
  • Philip J. Walther

      Affiliations

    • Nothing to disclose.
  • ,
  • Danielle A. Stackhouse

      Affiliations

    • Nothing to disclose.
  • ,
  • Benjamin D. Lack

      Affiliations

    • Nothing to disclose.
  • ,
  • David M. Albala

      Affiliations

    • Financial interest and/or other relationship with Applied Medical, Sanofi-Aventis and GlaxoSmithKline.
  • ,
  • Judd W. Moul

      Affiliations

    • Corresponding Author InformationCorrespondence: Division of Urologic Surgery and Duke Prostate Center, Duke University Medical Center, PO Box 3707, Durham, North Carolina 27710 (telephone: 919-684-5057; FAX: 919-684-8794)
    • Financial interest and/or other relationship with Sanofi-Aventis, Astra Zeneca, GlaxoSmithKline, Novartis and Theralogix.

Received 12 March 2009

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Study received institutional review board approval.

 Supported by research funds from the Committee for Urologic Research, Education, and Development (CURED) of Duke University.

 Editor's Note: This article is the second of 5 published in this issue for which category 1 CME credits can be earned. Instructions for obtaining credits are given with the questions on pages 2538 and 2539.

PII: S0022-5347(09)01763-7

doi: 10.1016/j.juro.2009.07.034

The Journal of Urology
Volume 182, Issue 5 , Pages 2242-2249 , November 2009